Allergy and Asthma Proceedings

Papers
(The H4-Index of Allergy and Asthma Proceedings is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Impact of steroids on the immune profiles of children with asthma living in the inner-city29
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination28
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis27
Future directions in allergen immunotherapy25
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks22
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis21
Venom allergen immunotherapy20
Operationalizing shared decision making in clinical practice20
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being20
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study20
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts19
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children19
For the Patient17
For the Patient17
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202217
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes16
0.42962217330933